# Alexion Pharmaceuticals, Inc. (ALXN)

Source: https://www.quantisnow.com/company/ALXN
Generated: 2026-11-19T02:52:09.817Z

- Ticker: ALXN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 1996

## Latest ALXN news and filings

- 2025-09-10 07:30 UTC [Conference Announcement] [Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer](https://www.quantisnow.com/insight/resolution-therapeutics-appoints-lucy-singah-as-chief-financial-officer-and-6195676)
- 2021-08-02 13:02 UTC [SEC Form 15-12G filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-alexion-pharmaceuticals-inc-1579046)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486714)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486712)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486711)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486705)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486704)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486703)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486702)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486701)
- 2021-07-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alexion-pharmaceuticals-inc-1486700)
- 2021-07-23 20:54 UTC [SEC Form 4] [SEC Form 4: COUGHLIN CHRISTOPHER J returned 42,347 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-coughlin-christopher-j-returned-42347-units-of-1481677)
- 2021-07-23 20:51 UTC [SEC Form 4] [SEC Form 4: FRIEDMAN PAUL A returned 12,840 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-friedman-paul-a-returned-12840-units-of-1481670)
- 2021-07-23 20:52 UTC [SEC Form 4] [SEC Form 4: SARIN ARADHANA returned 120,253 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-sarin-aradhana-returned-120253-units-of-common-1481664)
- 2021-07-23 20:49 UTC [SEC Form 4] [SEC Form 4: Reinsdorf Judith A returned 14,150 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-reinsdorf-judith-a-returned-14150-units-of-1481657)
- 2021-07-23 20:48 UTC [SEC Form 4] [SEC Form 4: Dunsire Deborah returned 14,629 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-dunsire-deborah-returned-14629-units-of-common-1481652)
- 2021-07-23 20:40 UTC [SEC Form 4] [SEC Form 4: Chiniara Ellen returned 116,850 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-chiniara-ellen-returned-116850-units-of-common-1481649)
- 2021-07-23 20:42 UTC [SEC Form 4] [SEC Form 4: Goff Brian returned 150,832 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-goff-brian-returned-150832-units-of-common-1481646)
- 2021-07-23 20:44 UTC [SEC Form 4] [SEC Form 4: Brennan David R returned 20,873 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-brennan-david-r-returned-20873-units-of-1481622)
- 2021-07-23 20:45 UTC [SEC Form 4] [SEC Form 4: Mollen John T returned 15,336 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-mollen-john-t-returned-15336-units-of-1481615)
- 2021-07-23 20:47 UTC [SEC Form 4] [SEC Form 4: Carino Tanisha returned 59,226 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-carino-tanisha-returned-59226-units-of-common-1481599)
- 2021-07-23 20:36 UTC [SEC Form 4] [SEC Form 4: Nader Francois returned 13,921 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-nader-francois-returned-13921-units-of-common-1481452)
- 2021-07-23 20:37 UTC [SEC Form 4] [SEC Form 4: Franchini Indrani Lall returned 116,075 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-franchini-indrani-lall-returned-116075-units-of-1481449)
- 2021-07-23 20:39 UTC [SEC Form 4] [SEC Form 4 filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-alexion-pharmaceuticals-inc-1481444)
- 2021-07-23 20:29 UTC [SEC Form 4] [SEC Form 4: ORLOFF JOHN J returned 146,511 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-orloff-john-j-returned-146511-units-of-1481337)
- 2021-07-23 20:32 UTC [SEC Form 4] [SEC Form 4: HANTSON LUDWIG returned 580,809 units of Common Stock to the company, decreasing direct ownership by 98% to 9,098 units](https://www.quantisnow.com/insight/sec-form-4-hantson-ludwig-returned-580809-units-of-common-1481300)
- 2021-07-23 20:34 UTC [SEC Form 4] [SEC Form 4: Rummelt Andreas returned 28,109 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-rummelt-andreas-returned-28109-units-of-common-1481290)
- 2021-07-22 13:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1458419)
- 2021-07-22 10:26 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1455001)
- 2021-07-22 10:26 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1455000)
- 2021-07-22 10:27 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1454999)
- 2021-07-22 10:24 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1454926)
- 2021-07-22 10:25 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1454925)
- 2021-07-22 10:24 UTC [SEC Form POS AM filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alexion-pharmaceuticals-inc-1454905)
- 2021-07-22 10:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454903)
- 2021-07-22 10:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454902)
- 2021-07-22 10:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454901)
- 2021-07-22 10:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454898)
- 2021-07-22 10:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454897)
- 2021-07-22 10:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alexion Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alexion-pharmaceuticals-inc-1454896)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALXN
- Earnings history: https://www.quantisnow.com/earnings/ALXN
- Dividend history: https://www.quantisnow.com/dividends/ALXN
- Insider transactions: https://www.quantisnow.com/insiders/ALXN
- Options chain: https://www.quantisnow.com/options/ALXN
- SEC 8-K filings only: https://www.quantisnow.com/company/ALXN/8-k
- RSS and alerts for ALXN: https://www.quantisnow.com/docs/rss-feeds.md
